{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:41:48Z","timestamp":1785404508360,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V109B-029"],"award-info":[{"award-number":["V109B-029"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program","award":["109-V-B-002"],"award-info":[{"award-number":["109-V-B-002"]}]},{"name":"Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program","award":["109-V-B-003"],"award-info":[{"award-number":["109-V-B-003"]}]},{"name":"Taipei Institute of Pathology","award":["TIP-108-004"],"award-info":[{"award-number":["TIP-108-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12022-020-09648-9","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T01:02:27Z","timestamp":1599094947000},"page":"348-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Detection of NTRK1\/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing"],"prefix":"10.1007","volume":"31","author":[{"given":"Yu-Cheng","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harn-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-2784","authenticated-orcid":false,"given":"Jen-Fan","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"9648_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317:1338-1348. https:\/\/doi.org\/10.1001\/jama.2017.2719","journal-title":"JAMA"},{"key":"9648_CR2","doi-asserted-by":"publisher","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1:e000023. https:\/\/doi.org\/10.1136\/esmoopen-2015-000023","journal-title":"ESMO Open"},{"key":"9648_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676-690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"key":"9648_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/path.5005","volume":"244","author":"J Liang","year":"2018","unstructured":"Liang J, Cai W, Feng D, Teng H, Mao F, Jiang Y, Hu S, Li X, Zhang Y, Liu B, Sun ZS (2018) Genetic landscape of papillary thyroid carcinoma in the Chinese population. J Pathol 244:215-226. https:\/\/doi.org\/10.1002\/path.5005","journal-title":"J Pathol"},{"key":"9648_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378:731-739. https:\/\/doi.org\/10.1056\/NEJMoa1714448","journal-title":"N Engl J Med"},{"key":"9648_CR6","doi-asserted-by":"publisher","unstructured":"Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, Blakely CM, Seto T, Cho BC, Tosi D, Besse B, Chawla SP, Bazhenova L, Krauss JC, Chae YK, Barve M, Garrido-Laguna I, Liu SV, Conkling P, John T, Fakih M, Sigal D, Loong HH, Buchschacher GL, Jr., Garrido P, Nieva J, Steuer C, Overbeck TR, Bowles DW, Fox E, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Demetri GD, trail investigators (2020) Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol 21:271-282. https:\/\/doi.org\/10.1016\/S1470-2045(19)30691-6","DOI":"10.1016\/S1470-2045(19)30691-6"},{"key":"9648_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/his.13845","volume":"75","author":"YP Hung","year":"2019","unstructured":"Hung YP, Jo VY, Hornick JL (2019) Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma. Histopathology 75:54-62. https:\/\/doi.org\/10.1111\/his.13845","journal-title":"Histopathology"},{"key":"9648_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00428-019-02640-7","volume":"476","author":"D Bell","year":"2020","unstructured":"Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK (2020) Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch 476:295-305. https:\/\/doi.org\/10.1007\/s00428-019-02640-7","journal-title":"Virchows Arch"},{"key":"9648_CR9","doi-asserted-by":"publisher","unstructured":"Guibourg B, Cloarec E, Conan-Charlet V, Quintin-Roue I, Grippari JL, Le Flahec G, Marcorelles P, Uguen A (2020) EPR17341 and A7H6R pan-TRK immunohistochemistry result in highly different staining patterns in a series of salivary gland tumors. Appl Immunohistochem Mol Morphol https:\/\/doi.org\/10.1097\/PAI.0000000000000825","DOI":"10.1097\/PAI.0000000000000825"},{"key":"9648_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13981","volume":"76","author":"B Xu","year":"2020","unstructured":"Xu B, Haroon Al Rasheed MR, Antonescu CR, Alex D, Frosina D, Ghossein R, Jungbluth AA, Katabi N (2020) Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion. Histopathology 76:375-382. https:\/\/doi.org\/10.1111\/his.13981","journal-title":"Histopathology"},{"key":"9648_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","volume":"42","author":"S Chiang","year":"2018","unstructured":"Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR (2018) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42:791-798. https:\/\/doi.org\/10.1097\/PAS.0000000000001055","journal-title":"Am J Surg Pathol"},{"key":"9648_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/his.13666","volume":"73","author":"YP Hung","year":"2018","unstructured":"Hung YP, Fletcher CDM, Hornick JL (2018) Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73:634-644. https:\/\/doi.org\/10.1111\/his.13666","journal-title":"Histopathology"},{"key":"9648_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","volume":"42","author":"ER Rudzinski","year":"2018","unstructured":"Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL (2018) Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors. Am J Surg Pathol 42:927-935. https:\/\/doi.org\/10.1097\/PAS.0000000000001062","journal-title":"Am J Surg Pathol"},{"key":"9648_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/PAS.0000000000001203","volume":"43","author":"JL Davis","year":"2019","unstructured":"Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER (2019) Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors. Am J Surg Pathol 43:435-445. https:\/\/doi.org\/10.1097\/PAS.0000000000001203","journal-title":"Am J Surg Pathol"},{"key":"9648_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/gcc.22767","volume":"58","author":"AJ Suurmeijer","year":"2019","unstructured":"Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Huang HY, Fletcher CD, Antonescu CR (2019) The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements. Genes Chromosom Cancer 58:739-746. https:\/\/doi.org\/10.1002\/gcc.22767","journal-title":"Genes Chromosom Cancer"},{"key":"9648_CR16","doi-asserted-by":"publisher","unstructured":"Rabban JT, Devine P, Sangoi AR, Poder L, Alvarez E, Davis JL, Rudzinski E, Garg K, Bean GR (2020) NTRK fusion cervical sarcoma: a report of 3 cases, emphasizing morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma. Histopathology. https:\/\/doi.org\/10.1111\/his.14069","DOI":"10.1111\/his.14069"},{"key":"9648_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.pathol.2020.02.004","volume":"52","author":"DD Wong","year":"2020","unstructured":"Wong DD, Vargas AC, Bonar F, Maclean F, Kattampallil J, Stewart C, Sulaiman B, Santos L, Gill AJ (2020) NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm. Pathology 52:401-409. https:\/\/doi.org\/10.1016\/j.pathol.2020.02.004","journal-title":"Pathology"},{"key":"9648_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/his.14010","volume":"76","author":"H Yamamoto","year":"2020","unstructured":"Yamamoto H, Nozaki Y, Kohashi K, Kinoshita I, Oda Y (2020) Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours. Histopathology 76:774-778. https:\/\/doi.org\/10.1111\/his.14010","journal-title":"Histopathology"},{"key":"9648_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","volume":"32","author":"Z Gatalica","year":"2019","unstructured":"Gatalica Z, Xiu J, Swensen J, Vranic S (2019) Molecular characterization of cancers with NTRK gene fusions. Mod Pathol 32:147-153. https:\/\/doi.org\/10.1038\/s41379-018-0118-3","journal-title":"Mod Pathol"},{"key":"9648_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33:38-46. https:\/\/doi.org\/10.1038\/s41379-019-0324-7","journal-title":"Mod Pathol"},{"key":"9648_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/cncr.28484","volume":"120","author":"RJ Leeman-Neill","year":"2014","unstructured":"Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY, Nikiforova MN, Yue NJ, Zhang M, Mabuchi K, Tronko MD, Nikiforov YE (2014) ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer 120:799-807. https:\/\/doi.org\/10.1002\/cncr.28484","journal-title":"Cancer"},{"key":"9648_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2350\/15-07-1667-OA.1","volume":"19","author":"JL Picarsic","year":"2016","unstructured":"Picarsic JL, Buryk MA, Ozolek J, Ranganathan S, Monaco SE, Simons JP, Witchel SF, Gurtunca N, Joyce J, Zhong S, Nikiforova MN, Nikiforov YE (2016) Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA\/RNA ThyroSeq v2 next-generation sequencing assay. Pediatr Dev Pathol 19:115-122. https:\/\/doi.org\/10.2350\/15-07-1667-OA.1","journal-title":"Pediatr Dev Pathol"},{"key":"9648_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/cncr.29887","volume":"122","author":"ML Prasad","year":"2016","unstructured":"Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE (2016) NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 122:1097-1107. https:\/\/doi.org\/10.1002\/cncr.29887","journal-title":"Cancer"},{"key":"9648_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/PAS.0000000000000814","volume":"41","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Chiosea SI, Liu CZ, Nikiforova M, Nikiforov YE (2017) Clinical and morphologic features of ETV6-NTRK3 translocated papillary thyroid carcinoma in an adult population without radiation exposure. Am J Surg Pathol 41:446-457. https:\/\/doi.org\/10.1097\/PAS.0000000000000814","journal-title":"Am J Surg Pathol"},{"key":"9648_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/EJE-17-0499","volume":"178","author":"AU Bastos","year":"2018","unstructured":"Bastos AU, de Jesus AC, Cerutti JM (2018) ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. Eur J Endocrinol 178:83-91. https:\/\/doi.org\/10.1530\/EJE-17-0499","journal-title":"Eur J Endocrinol"},{"key":"9648_CR26","doi-asserted-by":"publisher","unstructured":"Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nose V, Sadow PM (2020) Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod Pathol https:\/\/doi.org\/10.1038\/s41379-020-0574-4","DOI":"10.1038\/s41379-020-0574-4"},{"key":"9648_CR27","doi-asserted-by":"publisher","unstructured":"Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B (2020) RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas, Thyroid. https:\/\/doi.org\/10.1089\/thy.2019.0802","DOI":"10.1089\/thy.2019.0802"},{"key":"9648_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/his.12903","volume":"69","author":"JF Hang","year":"2016","unstructured":"Hang JF, Li AF, Chang SC, Liang WY (2016) Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Histopathology 69:54-62. https:\/\/doi.org\/10.1111\/his.12903","journal-title":"Histopathology"},{"key":"9648_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","volume":"31","author":"JM Cameselle-Teijeiro","year":"2018","unstructured":"Cameselle-Teijeiro JM, Peteiro-Gonzalez D, Caneiro-Gomez J, Sanchez-Ares M, Abdulkader I, Eloy C, Melo M, Amendoeira I, Soares P, Sobrinho-Simoes M (2018) Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/beta-catenin pathway. Mod Pathol 31:1168-1179. https:\/\/doi.org\/10.1038\/s41379-018-0070-2","journal-title":"Mod Pathol"},{"key":"9648_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/modpathol.2017.130","volume":"31","author":"RR Seethala","year":"2018","unstructured":"Seethala RR, Baloch ZW, Barletta JA, Khanafshar E, Mete O, Sadow PM, LiVolsi VA, Nikiforov YE, Tallini G, Thompson LD (2018) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol 31:39-55. https:\/\/doi.org\/10.1038\/modpathol.2017.130","journal-title":"Mod Pathol"},{"key":"9648_CR31","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW (2018) Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin Cancer Res 24:3059-3068. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0373","journal-title":"Clin Cancer Res"},{"key":"9648_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/ep:13:1:03","volume":"13","author":"YE Nikiforov","year":"2002","unstructured":"Nikiforov YE (2002) RET\/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3-16. https:\/\/doi.org\/10.1385\/ep:13:1:03","journal-title":"Endocr Pathol"},{"key":"9648_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","volume":"39","author":"A Chou","year":"2015","unstructured":"Chou A, Fraser S, Toon CW, Clarkson A, Sioson L, Farzin M, Cussigh C, Aniss A, O'Neill C, Watson N, Clifton-Bligh RJ, Learoyd DL, Robinson BG, Selinger CI, Delbridge LW, Sidhu SB, O'Toole SA, Sywak M, Gill AJ (2015) A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. Am J Surg Pathol 39:652-659. https:\/\/doi.org\/10.1097\/PAS.0000000000000368","journal-title":"Am J Surg Pathol"},{"key":"9648_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1097\/PAS.0000000000001366","volume":"43","author":"BT Harrison","year":"2019","unstructured":"Harrison BT, Fowler E, Krings G, Chen YY, Bean GR, Vincent-Salomon A, Fuhrmann L, Barnick SE, Chen B, Hosfield EM, Hornick JL, Schnitt SJ (2019) Pan-TRK immunohistochemistry: a useful diagnostic adjunct for secretory carcinoma of the breast. Am J Surg Pathol 43:1693-1700. https:\/\/doi.org\/10.1097\/PAS.0000000000001366","journal-title":"Am J Surg Pathol"},{"key":"9648_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/pin.12766","volume":"69","author":"A Remoue","year":"2019","unstructured":"Remoue A, Conan-Charlet V, Bourhis A, Flahec GL, Lambros L, Marcorelles P, Uguen A (2019) Non-secretory breast carcinomas lack NTRK rearrangements and TRK protein expression. Pathol Int 69:94-96. https:\/\/doi.org\/10.1111\/pin.12766","journal-title":"Pathol Int"},{"key":"9648_CR36","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","volume":"41","author":"JF Hechtman","year":"2017","unstructured":"Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA (2017) Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol 41:1547-1551. https:\/\/doi.org\/10.1097\/PAS.0000000000000911","journal-title":"Am J Surg Pathol"},{"key":"9648_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/PAS.0000000000001377","volume":"44","author":"J Lasota","year":"2020","unstructured":"Lasota J, Chlopek M, Lamoureux J, Christiansen J, Kowalik A, Wasag B, Felisiak-Golabek A, Agaimy A, Biernat W, Canzonieri V, Centonze G, Chmielik E, Daum O, Dubova M, Dziuba I, Goertz S, Gozdz S, Guttmejer-Nasierowska A, Haglund C, Halon A, Hartmann A, Inaguma S, Izycka-Swieszewska E, Kaczorowski M, Kita P, Kolos M, Kopczynski J, Michal M, Milione M, Okon K, Peksa R, Pyzlak M, Ristimaki A, Rys J, Szostak B, Szpor J, Szumilo J, Teresinski L, Waloszczyk P, Wejman J, Wesolowski W, Miettinen M (2020) Colonic adenocarcinomas harboring NTRK fusion genes: a clinicopathologic and molecular genetic study of 16 cases and review of the literature. Am J Surg Pathol 44:162-173. https:\/\/doi.org\/10.1097\/PAS.0000000000001377","journal-title":"Am J Surg Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09648-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-020-09648-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-020-09648-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:13:05Z","timestamp":1630685585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-020-09648-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9648"],"URL":"https:\/\/doi.org\/10.1007\/s12022-020-09648-9","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"24 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the IRB of Taipei Veterans General Hospital, which granted exemption of informed consent for tissue procurement through the Biobank of Taipei Veterans General Hospital after an unlinked anonymous process (IRB no.: 2019-07-001BC, Biobank no.: 10818).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}